Try our Advanced Search for more refined results
Competition
-
April 14, 2026
Apple Users Slam 'Distorted' Antitrust Depo Sanctions Bid
Phone users who accuse Google of suppressing rival search engines with anticompetitive deals slammed Apple's bid for sanctions over their counsel's allegedly "unrelenting and increasingly egregious" subpoena efforts, telling a California federal judge that the tech company's motion is based on a "distorted account of the discovery record."
-
April 14, 2026
Red State AGs Fight Bid To Trim Suit Against BlackRock
Republican attorneys general are opposing a bid by BlackRock and State Street to trim a suit accusing the asset managers of driving up coal prices, arguing that the firms' assertion that the suit cannot get past the U.S. Supreme Court's decision on federal antitrust damages claims is incorrect.
-
April 14, 2026
Trading Card Grading Deals Spark Antitrust Claims
Trading card collectors filed suit in California federal court Tuesday accusing Collectors Holdings Inc. of buying a pair of competitors in the trading card grading market in order to maintain its monopoly.
-
April 14, 2026
Agri Stats' Price-Fix Settlement Receives Chicken Judge's OK
An Illinois federal judge overseeing broiler chicken price-fixing litigation gave his early blessing Tuesday to a settlement that end users struck with Agri Stats Inc. that calls for the data service to either cease or substantially change the reports it compiles for protein industry subscribers.
-
April 14, 2026
Vertex Sues Former Exec To Block Move To Rival
Vertex Pharmaceuticals asked a Massachusetts state court judge to bar a former executive from taking a virtually identical role at competitor Vera Therapeutics, citing a noncompete agreement he allegedly signed.
-
April 14, 2026
Wash. Appeals Court Revives Podiatrist Trade Secrets Case
An appeals court in Washington state has reinstated a case brought by a Seattle-area podiatry practice against a former employee accused of stealing patient data for his separate practice.
-
April 14, 2026
No 7th Circ. Redux Yet For Comcast Against Ad Marker Suit
An Illinois federal judge refused to let Comcast seek immediate Seventh Circuit intervention against an order teeing up Viamedia's antitrust claims accusing it of forcing advertisers to use its internal ads system, concluding that nothing about the contested midcase question of market definition would speed up resolution.
-
April 14, 2026
3rd Circ. Upholds J&J Injunction Bid Loss In Biosimilar Fight
The Third Circuit on Tuesday ruled that a Johnson & Johnson subsidiary couldn't justify its bid for an order blocking Samsung Bioepis from paving the way for a Cigna unit to launch a generic version of an anti-inflammatory treatment.
-
April 14, 2026
Jeld-Wen, Steves Close The Door On 10-Year Merger Fight
The nearly decade-old fight between two doormakers, which resulted in the first-ever court ordered divestiture in a private merger challenge, is officially done and dusted after the Virginia federal court that has been overseeing the case granted Jeld-Wen's request to drop its claims.
-
April 14, 2026
U Of Iowa Sees 4 Wins Erased For NCAA Transfer Violation
The NCAA put the University of Iowa on one year's probation and vacated four 2023 football victories Tuesday, as punishment for the head coach and assistant tampering with an opposing player before he officially declared his plan to transfer.
-
April 14, 2026
Mich. AG Says PBMs Can't Duck Drug-Pricing Suit
Two pharmacy benefit managers can't dodge an antitrust lawsuit accusing them of price-fixing reimbursement rates because Michigan has properly claimed an antitrust violation, state Attorney General Dana Nessel told a federal court, asking it to toss aside the PBMs' dismissal bid.
-
April 14, 2026
OpenAI Says Musk Remedy Shift Leaves 'No Case Left To Try'
OpenAI is pushing back after Elon Musk said he would seek to have Sam Altman removed as the artificial intelligence company's CEO in a case challenging its conversion to a for-profit entity, telling a California federal court that the last-minute change adds a host of issues just weeks before trial.
-
April 14, 2026
Paul Weiss, Skadden Lead Amazon's $11.6B Globalstar Deal
Amazon.com Inc. said Tuesday it has agreed to purchase Globalstar Inc. for about $11.6 billion, part of an effort to build out its nascent Leo satellite internet business, with Paul Weiss Rifkind Wharton & Garrison LLP and Skadden Arps Slate Meagher & Flom LLP providing legal counsel on the deal.
-
April 14, 2026
Aerospace Firm Says Ex-Consultants Built 'Copycat' Rival
A woman-owned aerospace and defense manufacturing company accused its former business consultants in Colorado state court of conspiring to take its confidential information and form a "copycat" business, alleging they've deprived it of business opportunities and devalued its trade secrets.
-
April 13, 2026
Ill. Judge Wants More Proof To Recalculate Kickback Damages
An Illinois federal judge tasked with recalculating damages from a home health company's referral kickback scheme said Monday that she needs more complete and reliable evidence to help determine the appropriate amount, but allowed the government to continue offsetting Medicare payments as part of its judgment collection bid.
-
April 13, 2026
After NCAA's Win, Nevada Player Drops Eligibility Suit
A college baseball player who recently lost at the Ninth Circuit in his suit pushing the NCAA to let him play for a sixth season has dropped his antitrust lawsuit against the athletic association.
-
April 13, 2026
DC Circ. Digs Into FTC Rationale For Media Matters Probe
A D.C. Circuit panel tore into a Federal Trade Commission lawyer on Monday as the agency fought to convince the three judges that a lower court had no right to block it from investigating a left-leaning media watchdog, a probe the group claims is retaliation for publishing anti-Nazi content.
-
April 13, 2026
Mylan Can't Revive Copaxone Antitrust Claims Against Teva
A New Jersey federal judge sided Monday with a special master's recommendations to nix some of the parallel claims from Mylan and retailers like Walgreens accusing Teva of using regulatory deception, false advertising, improper rebates and more to delay generic competition to its Copaxone multiple sclerosis treatment.
-
April 13, 2026
Engineers Ask To Add Whistleblower To TikTok Sale Case
Software engineers from Alphabet and Meta are asking the D.C. Circuit for permission to update their petition challenging the Trump administration's handling of the TikTok U.S. divestiture, saying whistleblower allegations from a former ByteDance employee bolster their claim that the deal doesn't comply with Congress' mandate.
-
April 13, 2026
Catching Up With Delaware's Chancery Court
The Delaware Chancery Court's docket this past week featured a mix of high-stakes settlements, fast-moving deal litigation, governance disputes and a notable post-trial ruling involving fraud-tainted loans.
-
April 13, 2026
Calif. High Schools Resume Court Fight Against Athlete NIL
California's high school sports governing body has told a California federal court that the athletes demanding name, image and likeness rights again failed to prove that the state's ban eliminates competition for their talents.
-
April 13, 2026
Genius Wants Copy Of Settlement Between Sports Tech Rivals
Sports technology company Genius Sports Ltd. is asking a Texas federal court to compel Panda Interactive to follow the court's discovery order by sharing a copy of a settlement agreement Panda reached in a similar patent lawsuit with a different rival.
-
April 13, 2026
Stikeman-Led GFL Inks $4.6B Waste Management Deal
GFL Environmental Inc. has agreed to buy Secure Waste Infrastructure Corp. in a CA$6.4 billion ($4.6 billion) deal that would combine one of North America's largest waste haulers with a Western Canadian disposal and industrial waste infrastructure operator.
-
April 13, 2026
Startup's Ticketmaster Antitrust Suit May Get 2027 Trial Date
A California federal court tentatively scheduled an October 2027 trial for a shuttered startup's antitrust suit against Ticketmaster and Live Nation, after the startup claimed that Ticketmaster's exclusive agreements with venues thwarted its ability to compete in the ticketing business.
-
April 13, 2026
Chamber, Other Biz Groups Back Insulin Cos. At High Court
The U.S. Chamber of Commerce and other business groups urged the U.S. Supreme Court to take up an appeal from Sanofi-Aventis, Eli Lilly, Novo Nordisk and AstraZeneca, arguing the Second Circuit's revival of an antitrust suit risks opening up liability just for trade group membership.
Expert Analysis
-
Takeaways From 1st DOJ Antitrust Whistleblower Payout
The U.S. Justice Department's recent $1 million antitrust whistleblower reward accelerates the race to report by signaling that the Antitrust Division's program can result in substantial financial awards and reinforcing the need for corporate compliance programs that reach beyond core components, say attorneys at Pillsbury.
-
Series
Trail Running Makes Me A Better Lawyer
Navigating the muddy, root-filled path of trail marathons and ultramarathons provides fertile training ground for my high-stakes fractional general counsel work, teaching me to slow down my mind when the terrain shifts, sharpen my focus and trust my training, says Eric Proos at Next Era Legal.
-
Navigating New Risks Amid Altered Foreign Issuer Landscape
The U.S. Securities and Exchange Commission's potential rulemaking to redefine who qualifies as a foreign private issuer will shape securities regulation and enforcement for decades, affecting not only FPIs and U.S. investors but also the U.S.' position in global capital markets, says Elisha Kobre at Sheppard.
-
Reflections From High Court Oral Args Over Fed Gov. Removal
In the oral arguments last month for Trump v. Cook, which asks the U.S. Supreme Court to clarify the circumstances under which the president can remove a Federal Reserve Board governor, the justices appeared skeptical about ruling on the substantive issues in view of the limited record and analysis, say attorneys at Ballard Spahr.
-
CFIUS Risk Lessons From Chips Biz Divestment Order
President Donald Trump's January executive order directing HieFo to unwind its 2024 acquisition of a semiconductor business with ties to China underscores that even modestly sized transactions can attract CFIUS interest if they could affect strategic areas prioritized by the U.S. government, say attorneys at Debevoise.
-
Malpractice Claim Assignability Continues To Divide Courts
Recent decisions from courts across the country demonstrate how different jurisdictions balance competing policy interests in determining whether legal malpractice claims can be assigned, providing a framework to identify when and how to challenge any attempted assignment, says Christopher Blazejewski at Sherin & Lodgen.
-
Tips For Financial Advisers Facing TRO From Former Firm
The Eighth Circuit's recent decision in Choreo v. Lors, overturning a lower court's sweeping injunction after financial advisers moved to a new firm, gives advisers new strategies to fight restraining orders from their old firms, such as focusing on whether the alleged irreparable harm is calculable, say attorneys at Kutak Rock.
-
How Latest Nasdaq Proposals Stand To Raise Listings Quality
Nasdaq's recent proposals stand to heighten both quantitative and qualitative standards for issuers, which, if approved, may bring investors stronger market integrity and access but also raise the listings bar, say attorneys at Norton Rose.
-
Opinion
CFIUS Must Adapt To Current Foreign Investment Realities
To continue protecting the U.S.’ long-term strategic and economic interests, the Committee on Foreign Investment in the United States should implement practical enhancements that leverage technology, expertise and clear communication, and enable it to keep pace with evolving demands, says attorney Sohan Dasgupta.
-
Bipartisan Enforcement Is Rising In Consumer Finance
Activity over the past year suggests a bipartisan state enforcement wave is rippling across the consumer finance industry, which follows a blueprint set out by former Consumer Financial Protection Bureau Director Rohit Chopra, who notably now leads a Democratic Attorneys General Association working group, say attorneys at Hudson Cook.
-
Series
Teaching Logic Makes Me A Better Lawyer
Teaching middle and high school students the skills to untangle complicated arguments and identify faulty reasoning has made me reacquaint myself with the defined structure of thought, reminding me why logic should remain foundational in the practice of law, says Tom Barrow at Woods Rogers.
-
Series
Law School's Missed Lessons: Practicing Resilience
Resilience is a skill acquired through daily practices that focus on learning from missteps, recovering quickly without internalizing defeat and moving forward with intention, says Nicholas Meza at Quarles & Brady.
-
Upshot Of 'Skinny Label' Case May Go Beyond Pharma
The U.S. Supreme Court's pending review of Hikma v. Amarin, over a drugmaker's "skinny label," carries implications for both generics and brand-name pharmaceutical manufacturers, and could shed light on how inducement doctrine should operate in other regulated industries where products have substantial lawful uses, says Jason Shull at Banner Witcoff.
-
4 Lessons From FTC's Successful Bid To Block Edwards Deal
The Federal Trade Commission's recent victory in blocking Edwards Lifesciences' acquisition of JenaValve offers key insights for deals in life sciences and beyond, including considerations around nonprice dimensions and clear skies provisions, say attorneys at Orrick.
-
Assessing Factors Behind Biosimilar Uptake And Competition
As biosimilar uptake remains uneven and questions linger over whether the Biologics Price Competition and Innovation Act can deliver robust competition between biologics and biosimilars, a case study of Humira and its biosimilars illustrates how many factors, including payor reimbursement and formulary strategy, collectively shape competitive dynamics, say analysts at Analysis Group.